IGENE BIOTECHNOLOGY INC, 4, 2000-10-05

IGENE BIOTECHNOLOGY INC
4, 2000-10-05
AGRICULTURAL CHEMICALS

Previous: IGENE BIOTECHNOLOGY INC, SC 13D, 2000-10-05

Next: OXFORD TAX EXEMPT FUND II LTD PARTNERSHIP, 8-K, 2000-10-05

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

FORM 4
/ / Check this box if no longer
  subject to Section 16. Form 4
  or Form 5 obligations may
  continue.
  See Instruction 1(b)

OMB APPROVAL
OMB NUMBER: 3235-0287
Expires: December 31, 2001
Estimated average burden hours
per response.........0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940

(Print or Type Responses)

1. Name and Address of Reporting Person*

Kempner, Thomas L.

(Last) (First) (Middle)

2. Issuer Name and Ticker or Trading Symbol

IGENE BIOTECHNOLOGY, INC. (IGNE)

6. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)

____Director         _X_10% Owner
____Officer(give     ___Other (specify
   title below)                    below)
   ____________________________

c/o Loeb Partners Corporation
61 Broadway

(Street)

New York, N.Y. 10006

(City) (State) (Zip)

3. IRS
Identification
Number of
Reporting
Person, if an
entity
(Voluntary)

4.   Statement for
        Month/Year

  September 2000

5.    If Amendment,
     Date of Original
     (Month/Year)

7. Individual or Joint/Group (Check Applicable Line

_X_Form filed by One Reporting Person
___Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1. Title of Security
(Instr. 3)

2. Trans-
    action
    Date

     (Month/
     Day/
     Year)

3.Trans-
   action
   Code
   (Instr. 8)

Code     V

4. Securities Acquired (A)
     or Disposed of (D)
     (Instr. 3, 4 and 5)

Amount  (A)or (D)    Price

5. Amount of
     Securities
     Beneficially
     Owned at
     End of Month

(Instr. 3 and 4)

6. Owner-
     ship
     Form:
     Direct
     (D) or
     Indirect
     (I)
     (Instr. 4)

7. Nature of
     Indirect
     Beneficial
     Owner-
     ship

(Instr. 4)

Common Stock

386,972

Common Stock

1,482,987

Tte. of Tr.(1)

Common Stock

9/26

J(5)

625,000

8,166,916

Tte. of Tr.(2)

Common Stock

9/26

J(5)

625,000

8,126,918

Tte. of Tr.(3)

Common Stock

182,526

Tte. of Tr.(4)

(1)   Tte. of Trust for the benefit of Thomas L. Kempner, Alan H. Kempner, Jr.
(2)  Tte. of Trust for the benefit of Thomas L. Kempner
(3)  Tte. of Trust for the benefit of Alan H. Kempner, Jr.
(4)  Nan S. Kempner.
(5)  Shares were purchased as the fourth and final installment of a private placement
of February 8, 2000.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB-control number.

FORM 4 (continued)

Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1.  Title of Derivative
     Security
    (Instr. 3)

2. Conver-
   sion or
   Exercise
   Price of
   Deri-
   vative
   Security

3. Trans-
action
Date

(Month/
Day/
Year)

4. Trans-
   action
   Code
   Instr.
   (8)

Code    V

5. Number of
    Deriv-
    ative Securities
    Acquired
    (A) or Dis-
    posed of (D)
    (Instr. 3, 4, and
    5)

  (A)     (D)

6. Date Exer-
   cisable and
   Expiration
   Date
   (Month/Day/
   Year)

  Date     Expira-
  Exer-     tion
  cisable   Date

7. Title and Amount
  of Underlying
   Securities
  (Instr. 3 and 4)

  Title   Amount or
             Number of
             Shares

8. Price
of
Deriv-
ative
Secur-
ity
(Instr.
5)

9. Number
of deriv-
ative
Secur-
ities
Bene-
ficially
Owned
at End
of
Month
(Instr. 4)

10. Owner- ship
Form of
Deriv- ative
Security:
Direct
(D) or
Indirect
(I) (Instr. 4)

11. Nature
of
Indirect
Benefi-
cial
Owner
ship
(Instr. 4)

Warrants

Common

536,920

Warrants

Common

4,622,846

Tte. of Tr.(1)

Warrants

4/28/00

J(6)

2,500,000

Pres. 2/8/10

Common 2,500,000

26,606,399

Tte. of Tr.(2)

Warrants

4/28/00

J(6)

2,500,000

Pres. 2/8/10

Common 2,500,000

26,606,399

Tte. of Tr.(3)

Warrants

Common

98,650

Tte. of Tr.(4)

Explanation of Responses:

(6) Warrants received and stock purchased as part of a commitment to purchase up to $1,000,000 in Shares in four separate installments in a private placement of February 8, 2000. The balance of the warrants received were reflected in the August 2000 filing.

/s/ Thomas L. Kempner 10/5/00
**Signature of Reporting Person Date

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a)

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.